 |
市场调查报告书
商品编码
1789374
氧合器市场：依产品类型、患者类型、最终用户和地区划分Artificial Lung Market, By Product Type, By Patient Type, By End User, By Geography |
||||||
预计 2025 年人工肺市场价值将达到 21 亿美元，到 2032 年将达到 41.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 10.1%。
| 分析范围 | 分析详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 市场规模（2025年） | 21亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期间的复合年增长率（2025-2032年） | 10.10% | 预计金额（2032年） | 41.2亿美元 |
全球人工肺市场是更广泛的医疗设备产业的重要部分，专注于旨在暂时或永久取代严重呼吸系统疾病患者的自然肺功能的先进生命维持技术。
人工肺，又称为体外膜氧合 (ECMO) 系统或机械肺容量支持装置，是急性呼吸窘迫症候群(ARDS)、慢性阻塞性肺病(COPD)、肺动脉栓塞和其他危及生命的呼吸衰竭患者的重要治疗方案。这些先进的生物医学设备透过为血液供氧并排放体内二氧化碳来发挥作用，有效地执行健康肺部通常进行的气体交换功能。
该市场涵盖各种技术方案，包括膜式氧合器、人工肺植入和穿戴式人工肺系统，每种方案均旨在满足特定患者需求和临床场景。由于全球呼吸系统疾病的发生率不断上升、人口老化以及近期呼吸系统疫情的影响，人工肺市场正受到医疗保健提供者、医疗设备製造商和投资者的广泛关注，他们正在寻求创新解决方案，以应对重症加护挑战并改善加护治疗环境中患者的预后。
市场动态
全球人工肺市场的主要驱动力在于全球呼吸系统疾病（例如慢性阻塞性肺病、急性呼吸窘迫症候群和肺纤维化）的日益普及。这些疾病影响着全球整体数百万患者，并对先进的呼吸支援技术产生了巨大的需求。全球人口老化是市场成长的主要动力，因为老年人更容易患呼吸系统併发症，需要加护治疗。同时，生物相容性材料、小型化和气体交换效率的提高等技术进步正在提高人工肺系统的性能和安全性。
COVID-19 大流行凸显了对呼吸支援设备的迫切需求，并加速了市场扩张，特别是由于全球对医疗基础设施的投资增加。然而，市场成长面临重大限制因素，包括与人工肺设备及其维护相关的极高成本、可能延迟产品发布的复杂监管核准流程，以及与这些侵入性手术相关的严重併发症风险，如出血、感染和血栓症形成。缺乏受过操作先进人工肺系统训练的熟练医疗专业人员，再加上这些设备在新兴市场供应有限，进一步限制了市场渗透。儘管如此，正在进行的生物医学工程研究和开发中存在着巨大的商业机会，特别是可植入人工肺和可穿戴设备的开发，它们有可能彻底改变患者照护。
人工智慧和机器学习技术在预测性监测和自动调整方面的融合，为市场扩张提供了一条充满希望的途径，而新兴市场医疗支出的不断增长以及人们对先进呼吸护理解决方案的日益关注，也创造了新的成长机会。医疗设备製造商与医疗机构之间的战略伙伴关係，以及政府支持重症加护基础设施发展的倡议，预计将推动人工肺领域持续的市场成长和技术创新。
本报告的主要特点
- 本报告对全球氧合器市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
- 它还强调了每个领域的潜在商机，并描述了该市场的一系列有吸引力的投资提案。
- 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 全球氧合器市场的主要企业会根据以下参数进行分析，例如公司概况、产品系列、主要亮点、财务表现和策略。
- 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
- 《全球人工肺市场》报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过用于分析全球氧合器市场的各种策略矩阵更轻鬆地做出决策。
目录
第一章 分析目标与前提条件
- 分析目的
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章：市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 抑制因素
- 机会
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- 波特分析
- 企业合併（M&A）场景
- 产业趋势
第四章 全球製氧机市场依产品类型（2020-2032）
- 体外膜氧合（ECMO）系统
- 体外氧合器
- 植入式氧合器
- 其他（氧合设备）
5. 全球製氧机市场（依技术划分）（2020-2032）
- 灌注系统
- 膜氧合技术
- 微流体氧合装置
- 生物混合系统
- 无泵浦气体交换系统
- 其他（3D列印人工肺结构等）
6. 全球製氧机市场（依便携性划分） (2020-2032)
- 固定係统
- 可携式系统
- 穿戴式系统
7. 全球製氧机市场应用（2020-2032）
- 肺移植支持（移植桥接）
- 急性呼吸窘迫症候群（ARDS）
- 慢性呼吸道疾病（慢性阻塞性肺病、肺动脉高压、囊肿纤维化）
- 其他（冠状动脉绕道手术手术等）
8. 全球氧合器市场依病患类型划分（2020-2032 年）
- 新生
- 小儿科
- 成人
9. 全球製氧机市场（依最终用户划分）（2020-2032）
- 医院
- 移植中心
- 门诊手术中心
- 急救和创伤中心
- 居家医疗（针对穿戴式装置）
- 其他（研究机构等）
第 10 章 按地区分類的全球製氧机市场（2020-2032 年）
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第十一章竞争格局
- Medtronic plc
- Getinge AB
- LivaNova PLC
- Terumo Corporation
- Fresenius Medical Care AG & Co. KGaA
- ALung Technologies, Inc.
- Breethe, Inc.
- Miromatrix Medical Inc.
- Abiomed, Inc.
- Cyanagen Srl
- Nipro Corporation
- Hemovent GmbH
第十二章 分析师建议
- “命运之轮”
- 分析师观点
- Coherent Opportunity Map (COM)
第十三章参考文献与调查方法
- 参考
- 分析方法
- 关于 Coherent Market Insights
Artificial Lung Market is estimated to be valued at USD 2.10 Bn in 2025 and is expected to reach USD 4.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.10 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 10.10% | 2032 Value Projection: | USD 4.12 Bn |
The global artificial lung market represents a critical segment within the broader medical device industry, focusing on advanced life-support technologies designed to temporarily or permanently replace natural lung function in patients with severe respiratory conditions.
Artificial lungs, also known as extracorporeal membrane oxygenation (ECMO) systems or mechanical lung support devices, serve as vital therapeutic solutions for patients suffering from acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), pulmonary embolism, and other life-threatening respiratory failures. These sophisticated biomedical devices function by oxygenating blood and removing carbon dioxide outside the body, effectively performing the gas exchange function typically handled by healthy lungs.
The market encompasses various technological approaches, including membrane oxygenators, artificial lung implants, and wearable artificial lung systems, each designed to address specific patient needs and clinical scenarios. With the increasing prevalence of respiratory diseases globally, aging populations, and the recent impact of respiratory pandemics, the artificial lung market has gained significant attention from healthcare providers, medical device manufacturers, and investors seeking innovative solutions to address critical care challenges and improve patient outcomes in intensive care settings.
Market Dynamics
The global artificial lung market is primarily driven by the escalating prevalence of respiratory diseases worldwide, including chronic obstructive pulmonary disease, acute respiratory distress syndrome, and pulmonary fibrosis, which collectively affect millions of patients globally and create substantial demand for advanced respiratory support technologies. The aging global population significantly contributes to market growth, as elderly individuals are more susceptible to respiratory complications and require intensive care interventions, while technological advancements in biocompatible materials, miniaturization, and improved gas exchange efficiency have enhanced the performance and safety profiles of artificial lung systems.
The COVID-19 pandemic has particularly accelerated market expansion by highlighting the critical need for respiratory support devices and increasing healthcare infrastructure investments globally. However, market growth faces considerable restraints, including the extremely high costs associated with artificial lung devices and their maintenance, complex regulatory approval processes that can delay product launches, and the significant risk of complications such as bleeding, infection, and thrombosis associated with these invasive procedures. The shortage of skilled healthcare professionals trained in operating sophisticated artificial lung systems, coupled with limited availability of these devices in developing regions, further constrains market penetration. Nevertheless, substantial opportunities exist through ongoing research and development in bioengineering, particularly in developing implantable artificial lungs and wearable devices that could revolutionize patient care.
The integration of artificial intelligence and machine learning technologies for predictive monitoring and automated adjustments presents promising avenues for market expansion, while increasing healthcare expenditure in emerging markets and growing awareness about advanced respiratory care solutions create new growth opportunities. Strategic partnerships between medical device manufacturers and healthcare institutions, along with government initiatives supporting critical care infrastructure development, are expected to drive sustained market growth and innovation in the artificial lung sector.
Key Features of the Study
- This report provides in-depth analysis of the global artificial lung market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global artificial lung market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic plc, Getinge AB, LivaNova PLC, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA, ALung Technologies, Inc., Breethe, Inc., Miromatrix Medical Inc., Abiomed, Inc., Cyanagen Srl, Nipro Corporation, and Hemovent GmbH
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global artificial lung market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial lung market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Extracorporeal Membrane Oxygenation (ECMO) Systems
- Veno-Arterial (VA) ECMO
- Veno-Venous (VV) ECMO
- Paracorporeal Artificial Lungs
- Pumpless Paracorporeal Devices
- Pump-Assisted Paracorporeal Devices
- Implantable Artificial Lungs
- Intrathoracic Devices
- Vascular Graft-Integrated Devices
- Others (Oxygenators)
- Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Perfusion Systems
- Membrane Oxygenation Technology
- Microfluidic Oxygenators
- Biohybrid Systems
- Pumpless Gas Exchange Systems
- Others (3D-Printed Artificial Lung Constructs, etc.)
- Portability Insights (Revenue, USD Bn, 2020 - 2032)
- Stationary Systems
- Portable Systems
- Wearable Systems
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Lung Transplant Support (Bridge-to-Transplant)
- Acute Respiratory Distress Syndrome (ARDS)
- Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
- Others (Coronary Artery Bypass Grafting, etc.)
- Patient Type Insights (Revenue, USD Bn, 2020 - 2032)
- Neonates
- Pediatric
- Adult
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Transplant Centers
- Ambulatory Surgical Centers
- Emergency and Trauma Centers
- Home Care Settings (for wearable devices)
- Others (Research Institutes, etc.)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic plc
- Getinge AB
- LivaNova PLC
- Terumo Corporation
- Fresenius Medical Care AG & Co. KGaA
- ALung Technologies, Inc.
- Breethe, Inc.
- Miromatrix Medical Inc.
- Abiomed, Inc.
- Cyanagen Srl
- Nipro Corporation
- Hemovent GmbH
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Artificial Lung Market, By Product Type
- Global Artificial Lung Market, By Technology
- Global Artificial Lung Market, By Portability
- Global Artificial Lung Market, By Application
- Global Artificial Lung Market, By Patient Type
- Global Artificial Lung Market, By End User
- Global Artificial Lung Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Artificial Lung Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Extracorporeal Membrane Oxygenation (ECMO) Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Veno-Arterial (VA) ECMO
- Veno-Venous (VV) ECMO
- Paracorporeal Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pumpless Paracorporeal Devices
- Pump-Assisted Paracorporeal Devices
- Implantable Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intrathoracic Devices
- Vascular Graft-Integrated Devices
- Others (Oxygenators)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Artificial Lung Market, By Technology, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Perfusion Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Membrane Oxygenation Technology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Microfluidic Oxygenators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biohybrid Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pumpless Gas Exchange Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (3D-Printed Artificial Lung Constructs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Artificial Lung Market, By Portability, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Stationary Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Portable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Wearable Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Artificial Lung Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Lung Transplant Support (Bridge-to-Transplant)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Acute Respiratory Distress Syndrome (ARDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic Respiratory Conditions (COPD, Pulmonary Hypertension, Cystic Fibrosis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Coronary Artery Bypass Grafting, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Artificial Lung Market, By Patient Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Artificial Lung Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Emergency and Trauma Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Home Care Settings (for wearable devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Artificial Lung Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Portability, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Medical Care AG & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ALung Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Breethe, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miromatrix Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abiomed, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cyanagen Srl
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nipro Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hemovent GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
全球体外膜氧合套管市场
日本体外膜氧合机市场报告（按组件、模式、应用和地区）2025-2033
2026-2032 年体外膜氧合市场（按零件、服务、病患类型、应用和地区划分）
2025年全球体外膜氧合（ECMO）机市场报告2025年全球製氧机市场报告
体外膜氧合系统市场－全球产业规模、份额、趋势、机会及预测（按模式、应用、最终用户、地区和竞争细分，2020-2030 年）膜氧合器市场机会、成长动力、产业趋势分析与 2025 - 2034 年预测
体外循环系统市场：按产品类型、应用和最终用户划分 - 全球预测 2025-2030体外膜氧合装置市场：按模式、年龄、组件、应用和最终用户 - 2025-2030 年全球预测膜氧合市场：按类型、年龄层、应用划分 - 2025-2030 年全球预测